SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-059515
Filing Date
2020-05-11
Accepted
2020-05-11 16:04:19
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014593d1_10q.htm 10-Q 687596
2 EXHIBIT 31.1 tm2014593d1_ex31-1.htm EX-31.1 11584
3 EXHIBIT 31.2 tm2014593d1_ex31-2.htm EX-31.2 11352
4 EXHIBIT 32.1 tm2014593d1_ex32-1.htm EX-32.1 3814
5 EXHIBIT 32.2 tm2014593d1_ex32-2.htm EX-32.2 4033
6 GRAPHIC image_001.jpg GRAPHIC 17246
7 GRAPHIC image_002.jpg GRAPHIC 37298
  Complete submission text file 0001104659-20-059515.txt   3727330

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mrkr-20200331.xml EX-101.INS 863207
9 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20200331.xsd EX-101.SCH 38866
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrkr-20200331_cal.xml EX-101.CAL 29797
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrkr-20200331_def.xml EX-101.DEF 59185
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20200331_lab.xml EX-101.LAB 246511
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20200331_pre.xml EX-101.PRE 196351
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 20864711
SIC: 2834 Pharmaceutical Preparations